2000/111/EC: Commission Decision of 21 December 1999 designating a new antigen bank and making provisions for the transfer and storage of antigens within the framework of the Community action concerning reserves of foot-and-mouth disease vaccines (notified under document number C(1999) 4782

• Articles: 3

Article 1

1. Without prejudice to Article 3(1), first and second indent, of Decision 91/666/EEC an antigen bank shall be established at Merial SAS, Pirbright, United Kingdom.

2. The quantities and types of antigen stored in accordance with Decision 93/590/EC in the Community antigen bank at Institute for Animal Health, Pirbright, United Kingdom, shall be transferred for storage to Merial SAS, Pirbright, United Kingdom. The transfer shall be carried out under the responsability of Merial SAS.

3. The antigen purchased by the Community and assigned to the Community antigen bank in the premises of the Institute of Animal Health, Pirbright, in accordance with Decision 97/348/EC shall be stored in the premises of Merial SAS, Pirbright, United Kingdom.

4. To meet the objectives of paragraphs 2 and 3, the Commission shall conclude a contract, in the name of the European Community, with Merial SAS.

5. The Director-General of the Directorate-General responsible for Community veterinary legislation in the field of animal health shall be authorised to sign the contract on the transfer and storage of the quantities and types of antigen on behalf of the Commission of the European Communities.

Article 2

This Decision shall apply from 1 February 2000.

Article 3

This Decision is addressed to the Member States.

Done at Brussels, 21 December 1999.

For the Commission

David BYRNE

Member of the Commission

(1) OJ L 224, 18.8.1990, p. 19.

(2) OJ L 160, 26.6.1999, p. 103.

(3) OJ L 368, 31.12.1991, p. 21.

(4) OJ L 301, 24.11.1999, p. 6.

(5) OJ L 280, 13.11.1993, p. 33.

(6) OJ L 269, 11.11.1995, p. 29.

(7) OJ L 148, 6.6.1997, p. 27.